Promotion of atherogenesis by copper or iron-Which is more likely?

Biochemical and Biophysical Research Communications

Volumn 353, Issue 1, 2007, Pages 6-10

  Rajendran, Reshmi ^a   Ren, Minqin ^a   Ning, Pan ^a   Tan Kwong Huat, Benny ^a   Halliwell, Barry ^a   Watt, Frank ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Copper; Elemental analysis; Iron; Nuclear microscopy

Indexed keywords

CHOLESTEROL; COPPER; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; COPPER; IRON; MALE; RABBITS; TISSUE DISTRIBUTION;

ORYCTOLAGUS CUNICULUS;

EID: 33845617672     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.038     Document Type: Article

References (25)

1. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
2. American Heart Association, Heart and Stroke Statistical Update, 2001.
3. Stocker R., and Keaney Jr. J.F. New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 3 (2005) 1825-1834
4. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. fourth ed. (2006), Oxford University Press, Oxford
5. Watt F., Selley M., Thong P.S.P., and Tang S.M. Nuclear microscopy of atherosclerotic tissue. Nucl. Instrum. Meth. B 104 (1995) 356-360
6. Ponraj D., Makjanic J., Thong P.S., Tan B.K., and Watt F. The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion. FEBS Lett. 459 (1999) 218-222
7. Ren M., Watt F., Huat B.T., and Halliwell B. Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic. Biol. Med. 34 (2003) 746-752
8. Ren M., Rajendran R., Pan N., Tan B.K., Ong W.Y., Watt F., and Halliwell B. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic. Biol. Med. 38 (2005) 1206-1211
9. Esterbauer H., Gebicki J., Puhl H., and Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13 (1992) 341-390
10. Smith C., Mitchinson M.J., Aruoma O.I., and Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286 (1992) 901-905
11. Ehrenwald E., and Fox P.L. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J. Clin. Invest. 97 (1996) 884-890
12. Watt F., van Kan J.A., Rajta I., Bettiol A.A., Choo T.F., Breese M.B.H., and Osipowicz T. The National University of Singapore high energy ion nano-probe facility: performance tests. Nucl. Instrum. Meth. B 210 (2003) 14-20
13. Alissa E.M., Bahijri S.M., Lamb D.J., and Ferns G.A. The effects of coadministration of dietary copper and zinc supplements on atherosclerosis, antioxidant enzymes and indices of lipid peroxidation in the cholesterol-fed rabbit. Int. J. Exp. Pathol. 85 (2004) 265-275
14. Ren M., Rajendran R., Pan N., Tan B.K.H., Ong C.N., Watt F., and Halliwell B. Zinc supplementation decreases the development of atherosclerosis in rabbits. Free Radic. Biol. Med. 41 (2006) 222-225
15. Lamb D.J., Reeves G.L., Taylor A., and Ferns G.A. Dietary copper supplementation reduces atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 146 (1999) 33-43
16. Leake D.S. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?. Atherosclerosis 129 (1997) 149-157
17. Rodriguez-Malaver A.J., Leake D.S., and Rice-Evans C.A. The effects of pH on the oxidation of low-density lipoprotein by copper and metmyoglobin are different. FEBS Lett. 406 (1997) 37-41
18. Lamb D.J., Tickner M.L., Hourani S.M., and Ferns G.A. Dietary copper supplements modulate aortic superoxide dismutase, nitric oxide and atherosclerosis. Int. J. Exp. Pathol. 86 (2005) 247-255
19. Halliwell B., and Gutteridge J.M. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280 (1990) 1-8
20. Ferns G.A., Lamb D.J., and Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 133 (1997) 139-152
21. Fields M., and Lewis C.G. Benfluorex, a hypotriglyceridemic drug, reduces lipid peroxidation and alleviates adverse metabolic complications of copper deficiency. Nutrition 13 (1997) 895-899
22. Mazur A., Gueux E., Bureau I., Feillet-Coudray C., Rock E., and Rayssiguier Y. Copper deficiency and lipoprotein oxidation. Atherosclerosis 137 (1998) 443-445
23. Saari J.T. Evidence that dimethyl sulfoxide inhibits defects of copper deficiency by inhibition of glycation. Nutr. Res. 16 (1996) 467-477
24. Rayssiguier Y., Gueux E., Bussiere L., and Mazur A. Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats. J. Nutr. 123 (1993) 1343-1348
25. Jones A.A., DiSilvestro R.A., Coleman M., and Wagner T.L. Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk. Metabolism 46 (1997) 1380-1383